Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences ROE 2010-2024 | USNA

Current and historical return on equity (ROE) values for USANA Health Sciences (USNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
USANA Health Sciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.06B $0.50B 12.81%
2023-12-31 $0.06B $0.50B 13.33%
2023-09-30 $0.06B $0.47B 12.91%
2023-06-30 $0.06B $0.47B 14.25%
2023-03-31 $0.07B $0.46B 15.26%
2022-12-31 $0.07B $0.43B 16.84%
2022-09-30 $0.08B $0.41B 19.00%
2022-06-30 $0.09B $0.40B 22.17%
2022-03-31 $0.11B $0.39B 26.70%
2021-12-31 $0.12B $0.40B 28.71%
2021-09-30 $0.14B $0.40B 32.71%
2021-06-30 $0.14B $0.42B 33.88%
2021-03-31 $0.13B $0.40B 32.85%
2020-12-31 $0.13B $0.44B 33.64%
2020-09-30 $0.12B $0.39B 33.24%
2020-06-30 $0.11B $0.35B 33.01%
2020-03-31 $0.10B $0.32B 30.12%
2019-12-31 $0.10B $0.35B 27.76%
2019-09-30 $0.10B $0.31B 27.30%
2019-06-30 $0.11B $0.38B 26.97%
2019-03-31 $0.12B $0.39B 29.39%
2018-12-31 $0.13B $0.39B 30.42%
2018-09-30 $0.09B $0.44B 21.61%
2018-06-30 $0.08B $0.43B 20.82%
2018-03-31 $0.07B $0.40B 18.54%
2017-12-31 $0.06B $0.36B 16.95%
2017-09-30 $0.09B $0.36B 25.26%
2017-06-30 $0.10B $0.38B 28.03%
2017-03-31 $0.10B $0.35B 31.40%
2016-12-31 $0.10B $0.33B 34.72%
2016-09-30 $0.10B $0.31B 36.82%
2016-06-30 $0.10B $0.27B 35.22%
2016-03-31 $0.10B $0.25B 34.52%
2015-12-31 $0.10B $0.28B 33.57%
2015-09-30 $0.09B $0.31B 34.04%
2015-06-30 $0.09B $0.29B 35.16%
2015-03-31 $0.08B $0.25B 33.76%
2014-12-31 $0.08B $0.23B 31.57%
2014-09-30 $0.08B $0.20B 30.18%
2014-06-30 $0.07B $0.25B 28.24%
2014-03-31 $0.08B $0.28B 31.39%
2013-12-31 $0.08B $0.26B 35.03%
2013-09-30 $0.08B $0.24B 37.24%
2013-06-30 $0.08B $0.21B 39.24%
2013-03-31 $0.07B $0.19B 37.09%
2012-12-31 $0.07B $0.19B 34.83%
2012-09-30 $0.06B $0.20B 32.71%
2012-06-30 $0.06B $0.18B 31.64%
2012-03-31 $0.05B $0.19B 31.45%
2011-12-31 $0.05B $0.17B 31.50%
2011-09-30 $0.05B $0.16B 32.24%
2011-06-30 $0.05B $0.15B 34.54%
2011-03-31 $0.05B $0.15B 35.61%
2010-12-31 $0.05B $0.15B 39.83%
2010-09-30 $0.04B $0.13B 45.24%
2010-06-30 $0.04B $0.10B 48.45%
2010-03-31 $0.04B $0.09B 53.62%
2009-12-31 $0.03B $0.07B 58.87%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.862B $0.921B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.103B 32.16
Chugai Pharmaceutical (CHGCY) Japan $58.463B 26.13
Takeda Pharmaceutical (TAK) Japan $40.953B 8.29
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.843B 28.17
Sandoz Group AG (SDZNY) Switzerland $15.602B 0.00
United Therapeutics (UTHR) United States $14.130B 15.06
Neurocrine Biosciences (NBIX) United States $13.855B 37.93
Shionogi (SGIOY) Japan $11.518B 10.01
Catalent (CTLT) United States $10.177B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.450B 0.00
Ionis Pharmaceuticals (IONS) United States $6.957B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.731B 7.40
Revolution Medicines (RVMD) United States $6.403B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.971B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.475B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.532B 0.00
Corcept Therapeutics (CORT) United States $3.383B 30.65
Arrowhead Pharmaceuticals (ARWR) United States $3.228B 0.00
Dyne Therapeutics (DYN) United States $3.084B 0.00
PTC Therapeutics (PTCT) United States $2.345B 0.00
Indivior (INDV) United States $2.223B 10.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.960B 11.14
Catalyst Pharmaceuticals (CPRX) United States $1.830B 17.81
Recursion Pharmaceuticals (RXRX) United States $1.782B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.728B 0.00
Ardelyx (ARDX) United States $1.724B 0.00
Evotec AG (EVO) Germany $1.701B 0.00
Soleno Therapeutics (SLNO) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.351B 0.00
Pacira BioSciences (PCRX) United States $1.332B 12.66
BioCryst Pharmaceuticals (BCRX) United States $1.275B 0.00
Xencor (XNCR) United States $1.167B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.162B 0.00
Enliven Therapeutics (ELVN) United States $1.099B 0.00
4D Molecular Therapeutics (FDMT) United States $1.085B 0.00
Ocular Therapeutix (OCUL) United States $1.059B 0.00
Collegium Pharmaceutical (COLL) United States $1.053B 6.30
Ironwood Pharmaceuticals (IRWD) United States $1.021B 15.90
Centessa Pharmaceuticals (CNTA) United Kingdom $0.907B 0.00
Cronos Group (CRON) Canada $0.891B 0.00
Relay Therapeutics (RLAY) United States $0.865B 0.00
ARS Pharmaceuticals (SPRY) United States $0.825B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.815B 0.00
Harrow (HROW) United States $0.739B 0.00
Sage Therapeutics (SAGE) United States $0.654B 0.00
Exscientia (EXAI) United Kingdom $0.617B 0.00
Cassava Sciences (SAVA) United States $0.593B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.564B 0.00
Savara (SVRA) United States $0.557B 0.00
Siga Technologies (SIGA) United States $0.540B 6.90
Lexeo Therapeutics (LXEO) United States $0.528B 0.00
Heron Therapeutics (HRTX) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.497B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.484B 0.00
Altimmune (ALT) United States $0.472B 0.00
Larimar Therapeutics (LRMR) United States $0.463B 0.00
Bioventus (BVS) United States $0.455B 17.42
OmniAb (OABI) United States $0.441B 0.00
Esperion Therapeutics (ESPR) United States $0.421B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Verve Therapeutics (VERV) United States $0.410B 0.00
Organogenesis (ORGO) United States $0.371B 70.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Xeris Biopharma Holdings (XERS) United States $0.334B 0.00
Tourmaline Bio (TRML) United States $0.330B 0.00
Korro Bio (KRRO) United States $0.314B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.309B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.94
Enanta Pharmaceuticals (ENTA) United States $0.275B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.245B 0.00
Aquestive Therapeutics (AQST) United States $0.237B 0.00
Nanobiotix S.A (NBTX) France $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.233B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Century Therapeutics (IPSC) United States $0.215B 0.00
Akebia Therapeutics (AKBA) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.213B 19.90
Eliem Therapeutics (ELYM) United States $0.212B 0.00
Prelude Therapeutics (PRLD) United States $0.209B 0.00
Profound Medical (PROF) Canada $0.205B 0.00
Zevra Therapeutics (ZVRA) United States $0.205B 0.00
Fractyl Health (GUTS) United States $0.205B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.197B 0.00
Pyxis Oncology (PYXS) United States $0.195B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Acrivon Therapeutics (ACRV) United States $0.179B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Metagenomi (MGX) United States $0.153B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.144B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Telomir Pharmaceuticals (TELO) United States $0.142B 0.00
Galectin Therapeutics (GALT) United States $0.140B 0.00
Cardiol Therapeutics (CRDL) Canada $0.139B 0.00
CytoDyn (CYDY) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.64
VAXART, INC (VXRT) United States $0.118B 0.00
Assertio Holdings (ASRT) United States $0.118B 5.39
OptiNose (OPTN) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.117B 0.00
Journey Medical (DERM) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.108B 0.00
Citius Pharmaceuticals (CTXR) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
FibroGen (FGEN) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
AlloVir (ALVR) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
Conduit Pharmaceuticals (CDT) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.076B 1.06
CASI Pharmaceuticals (CASI) China $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.053B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Tempest Therapeutics (TPST) United States $0.049B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Inotiv (NOTV) United States $0.043B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
DURECT (DRRX) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.026B 0.00
BioVie (BIVI) United States $0.025B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Viracta Therapeutics (VIRX) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Cosmos Health (COSM) Greece $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
SHINECO (SISI) China $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.08